In these interviews, we speak to four early career researchers whose respective research findings were highlighted by the Society as ones to watch in the coming years.
This review from Biomarkers in Medicine examines the usefulness of telomere length as biomarkers for neurological conditions such as Alzheimer’s, Parkinson’s and autism.
A study from Neurodegenerative Disease Management explores the lack of understanding around juvenile Huntington’s disease and its symptoms.
A series of research presented at SfN’s Neuroscience 2017 has shed more light on the mechanism by which stress negatively impacts the brain, potentially highlighting future therapeutics.
Research presented at SfN’s Neuroscience 2017 has highlighted novel applications of genetic and cellular techniques that may help us to better understand neurological disorders such as addiction and Zika.
An international consortium has used mouse knockouts to identify 52 novel genes associated with hearing.
Genetic variant relating to protein involved in neurotransmission may affect brain’s ability to regulate emotion.
Read the third and final installment of our debate, which looks ahead at future research trends and the potential for personalized medicine.
Read the second installment of our Alzheimer’s genetics debate, with this part focusing on current research priorities, challenges and ethical concerns.
In the first installment of this debate, our experts discuss the contribution of genetics to Alzheimer’s risk, the differences between early- and late-onset disease, and how new technologies have advanced our understanding of this ever-expanding field.